Rare diseases
Investigational molecules
Locations
Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration
ItalyStudy of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back
ItalyTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
ItalyStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
ItalyA study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia
ItalyA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
ItalyStudy comparing datopotamab deruxtecan with or without durvalumab to chemotherapy with pembrolizumab for patients with triple-negative breast cancer
ItalyA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
ItalyA study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene
ItalyA Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis
ItalyA Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment
ItalyA Study of Olpasiran for Patients With Stable Heart and Blood Vessel Disease and High Lipoprotein(a) to Measure Changes in Artery Plaque Using Heart Scans
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
